A5003322190- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Practices and Patient Outcomes
- Advances in Oncology and Radiotherapy
- Economic and Financial Impacts of Cancer
- Hepatitis C virus research
- Blood Pressure and Hypertension Studies
- Prenatal Screening and Diagnostics
- Autism Spectrum Disorder Research
- Cancer Genomics and Diagnostics
- Healthcare Policy and Management
- Systemic Lupus Erythematosus Research
- Healthcare cost, quality, practices
- Venous Thromboembolism Diagnosis and Management
- Liver Disease Diagnosis and Treatment
- Ethics in Clinical Research
- Hemoglobinopathies and Related Disorders
- Bone health and treatments
- Multiple Sclerosis Research Studies
- Iron Metabolism and Disorders
- Acute Lymphoblastic Leukemia research
- Global Health Care Issues
- Cancer Treatment and Pharmacology
- Balance, Gait, and Falls Prevention
- Liver Disease and Transplantation
- Health and Medical Research Impacts
University of Washington
2021-2024
Mercer Island School District
2024
University of Cincinnati
2019-2020
Objective The growing deprescribing field is challenged by a lack of consensus around evidence and knowledge gaps. objective this overview systematic reviews was to summarize the review for interventions in older adults. Methods 11 databases were searched from 1 st January 2005 16 th March 2023 identify reviews. We summarized synthesized results two steps. Step reported included (including meta-analyses). 2 involved narrative synthesis outcome. Outcomes medication-related outcomes ( e . g .,...
Little is known regarding the geographic disparity in distribution of phase 1-3 clinical trials new cancer treatments US and associated factors.
Objectives Between 2013–2019, several all-oral direct-acting antivirals (DAAs) were launched with the potential to cure patients hepatitis C virus (HCV). They generated economic value in terms of health gains for and cost-savings US healthcare system. We estimated share this allocated four manufacturers vs society. Methods For 2015–2019, we incremental impact DAAs on HCV outcomes costs. used CDAF Polaris Observatory database estimate utilization. Per-patient projections lifetime...
e24004 Background: Survival benefit from current anticancer treatments, even if modest, improves a patient’s chances of accessing and benefiting future innovations currently in clinical development. No studies to date have evaluated the potential impact on oncologists’ treatment recommendations. Methods: We conducted national survey medical hematologic oncologists (n = 200) how expectations about may influence their recommendations today. The described hypothetical patient with metastatic...
Abstract Background : Rigorous evidence to guide deprescribing is limited, and priorities inform research practice remain unclear. The objective of this overview systematic reviews (i.e. reviews) was synthesize the available review regarding effectiveness interventions deprescribe medications in older adults. Methods 11 databases were searched from January 2005 October 2020. We included randomized or non-randomized controlled designs. Two independent reviewers screened extracted data....